Exon deletion patterns of the dystrophin gene in 82 Vietnamese Duchenne/Becker muscular dystrophy patients

Journal of Neurogenetics

Volumn 27, Issue 4, 2013, Pages 170-175

  Tran, Van Khanh ^a   Ta, Van Thanh ^a   Vu, Dung Chi ^b   Nguyen, Suong Thi Bang ^a   Do, Hai Ngoc ^a   Ta, Minh Hieu ^a   Tran, Thinh Huy ^a   Matsuo, Masafumi ^c  

^a HANOI MEDICAL UNIVERSITY   (Viet Nam)

^b NATIONAL HOSPITAL OF PEDIATRICS   (Viet Nam)

^c KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

Deletion; Duchenne Becker muscular dystrophy; Dystrophin; Exon skipping

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; COMPLEMENTARY DNA; DYSTROPHIN; MESSENGER RNA;

ADOLESCENT; ADULT; ANTISENSE THERAPY; ARTICLE; BECKER MUSCULAR DYSTROPHY; CHILD; CONTRACTURE; DNA DETERMINATION; DNA SEQUENCE; DUCHENNE MUSCULAR DYSTROPHY; EXON; EXON SKIPPING; GENE DELETION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; LEG MUSCLE; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; MULTIPLEX POLYMERASE CHAIN REACTION; MUSCLE ATROPHY; MUSCLE WEAKNESS; PRIORITY JOURNAL; SCHOOL CHILD; VIET NAM;

ADOLESCENT; ADULT; AGE OF ONSET; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; DYSTROPHIN; EXONS; GENE DELETION; GENETIC THERAPY; GENOTYPE; HUMANS; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; MUSCULAR DYSTROPHY, DUCHENNE; PHENOTYPE; YOUNG ADULT;

EID: 84889248320     PISSN: 01677063     EISSN: 15635260     Source Type: Journal    
DOI: 10.3109/01677063.2013.830616     Document Type: Article

References (26)

1. Aoki, Y., Nakamura, A., Yokota, T., Saito, T., Okazawa, H., Nagata, T., & Takeda, S. (2010). In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-defi cient mdx mouse. Mol Ther, 18, 1995-2005.
2. Beggs, A. H., Koenig, M., Boyce, F. M., & Kunkel, L. M. (1990). Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet, 86, 45-48.
3. Bennett R. R., den Dunnen J., O ' Brien, K. F., Darras, B. T., & Kunkel, L. M. (2001). Detection of mutations in the dystrophin gene via automated DHPLC screening and direct sequencing. BMC Genet, 2, 17.
4. Carsana, A., Frisso, G., Tremolaterra, M. R., Lanzillo, R., Vitale, D. F., Santoro, L., & Salvatore, F. (2005). Analysis of dystrophin gene deletions indicates that the hinge III region of the protein correlates with disease severity. Ann Hum Genet, 69, 253-259.
5. Chamberlain, J. S., Gibbs, R. A., Ranier, J. E., Nguyen, P. N., & Caskey, C. T. (1988). Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplifi cation. Nucleic Acids Res, 16, 11141-11156.
6. Cirak, S., Arechavala-Gomeza, V., Guglieri, M., Feng, L., Torelli, S., Anthony, K., Abbs, S., Garralda, M. E., Bourke, J., Wells, D. J., Dickson, G., Wood, M. J., Wilton, S. D., Straub, V., Kole, R., Shrewsbury, S. B., Sewry, C., Morgan, J. E., Bushby, K., & Muntoni, F. (2011). Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: An open-label, phase 2, dose-escalation study. Lancet, 378, 595-605.
7. Gilgenkrantz, H., Chelly, J., Lambert, M., Ré can, D., Barbot, J. C., van Ommen, G. J., & Kaplan, J. C. (1989). Analysis of molecular deletions with cDNA probes in patients with Duchenne and Becker muscular dystrophies. Genomics, 5, 574-580.
8. Incitti, T., De Angelis, F. G., Cazzella, V., Sthandier, O., Pinnar ò, C., Legnini, I., & Bozzoni, I. (2010). Exon skipping and duchenne muscular dystrophy therapy: Selection of the most active U1 snRNA antisense able to induce dystrophin exon 51 skipping. Mol Ther, 18, 1675-1682.
9. Katayama, Y., Tran, V. K., Hoan, N. T., Zhang, Z., Goji, K., Yagi, M., Takeshima, Y., Saiki, K., Nhan, N. T., & Matsuo, M. (2010). Co-occurrence of mutations in both dystrophin-and androgen-receptor genes is a novel cause of female Duchenne muscular dystrophy. Hum Genet, 119, 516-5199.
10. Kinali, M., Arechavala-Gomeza, V., Feng, L., Cirak, S., Hunt, D., Adkin, C., Guglieri, M., Ashton, E., Abbs, S., Nihoyannopoulos, P., Garralda, M. E., Rutherford, M., McCulley, C., Popplewell, L., Graham, I. R., Dickson, G., Wood, M. J., Wells, D. J., Wilton, S. D., Kole, R., Straub, V., Bushby, K., Sewry, C., Morgan, J. E., & Muntoni, F. (2009). Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: A single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol, 8, 918-928.
11. Koenig, M., Beggs, A. H., Moyer, M., Scherpf, S., Heindrich, K., Bettecken, T., Meng, G., Muller, C. R., Lindlöf, M., Kaariainen, H., de la Chapelle, A., Kiuru, A., Savontaus, M. L., Gilgenkrantz, H., Récan, D., Chelly, J., Kaplan, J. C., Covone, A. E., Archidiacono, N., Romeo, G., Liechti-Gallati, S., Schneider, V., Braga, S., Moser, H., Darras, B. T., Murphy, P., Francke, U., Chen, J. D., Morgan, G., Denton, M., Greenberg, C. R., Wrogemann, K., Blonden, L. A. J., van Paassen, H. M. B., van Ommen, G. J. B., & Kunkel, L. M. (1989). The molecular basis for Duchenne versus Becker muscular dystrophy: Correlation of severity with type of deletion. Am J Hum Genet, 45, 498-506.
12. Lai, P. S., Takeshima, Y., Adachi, K., Van Tran, K., Nguyen, H. T., Low, P. S., & Matsuo M. (2002). Comparative study on deletions of the dystrophin gene in three Asian populations. J Hum Genet, 47, 552-555.
13. Lalic, T., Vossen, R. H., Coffa, J., Schouten, J. P., Guc-Scekic, M., Radivojevic, D., Djurisic, M., Breuning, M. H., White, S. J., & den Dunnen, J. T. (2005). Deletion and duplication screening in the DMD gene using MLPA. Eur J Hum Genet, 13, 1231-1234.
14. Matsuo, M., Masumura, T., Nishio, H., Nakajima, T., Kitoh, Y., Takumi, T., Koga, J., & Nakamura, H. (1991). Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy Kobe. J Clin Invest, 87, 2127-2131.
15. Monaco, A. P., Bertelson, C. J., Liechti-Gallati, S., Moser, H., & Kunkel, L. M. (1988). An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics, 2, 90-95.
16. Nishiyama, A., Takeshima, Y., Zhang, Z., Habara, Y., Tran, T. H., Yagi, M., & Matsuo M. (2008). Dystrophin nonsense mutations can generate alternative rescue transcripts in lymphocytes. Ann Hum Genet, 72, 717-724.
17. Okizuka, Y., Takeshima, Y., Awano, H., Zhang, Z., Yagi, M., & Matsuo, M. (2009). Small mutations detected by multiplex ligation-dependent probe amplifi cation of the dystrophin gene. Genet Test Mol Biomarkers, 13, 427-431.
18. Roberts, R. G., Barby, T. F., Manners, E., Bobrow, M., & Bentley, D. R. (1991). Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. Am. J. Hum Genet, 49, 298-310.
19. Schwartz, M., & Dunø, M. (2004). Improved molecular diagnosis of dystrophin gene mutations using the multiplex ligationdependent probe amplifi cation method. Genet Test, 8, 361-367.
20. Takeshima, Y., Yagi, M., Okizuka, Y., Awano, H., Zhang, Z., Yamauchi, Y., Nishio, H., & Matsuo, M. (2010). Mutation spectrum of the dystrophin gene in 442 Duchenne/Becker muscular dystrophy cases from one Japanese referral center. J Hum Genet, 55, 379-388.
21. Takeshima, Y., Yagi, M., Wada, H., Ishibashi, K., Nishiyama, A., Kakumoto, M., Sakaeda, T., Saura, R., Okumura, K., & Matsuo, M. (2006). Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy. Pediatr Res, 59, 690-694.
22. Tran, V. K., Takeshima, Y., Zhang, Z., Yagi, M., Nishiyama, A., Habara, Y., & Matsuo, M. (2006). Splicing analysis disclosed a determinant single nucleotide for exon skipping caused by a novel intra-exonic four-nucleotide deletion in the dystrophin gene. J Med Genet, 43, 924-930.
23. Tran, V. K., Takeshima, Y., Zhang, Z., Habara, Y., Haginoya, K., Nishiyama, A., Yagi, M., & Matsuo, M. (2007). A nonsense mutation-created intraexonic splice site is active in the lymphocytes, but not in the skeletal muscle of a DMD patient. Hum Genet, 120, 737-742.
24. Tran, V. K., Zhang, Z., Yagi, M., Nishiyama, A., Habara, Y., Takeshima, Y., & Matsuo, M. (2005). A novel cryptic exon identifi ed in the 3 ' region of intron 2 of the human dystrophin gene. J Hum Genet, 50, 425-433.
25. van Deutekom, J. C., Janson, A. A., Ginjaar, I. B., Frankhuizen, W. S., Aartsma-Rus, A., Bremmer-Bout, M., den Dunnen, J. T., Koop, K., van der Kooi, A. J., Goemans, N. M., de Kimpe, S. J., Ekhart, P. F., Venneker, E. H., Platenburg, G. J., Verschuuren, J. J., & van Ommen, G. J. (2007). Local dystrophin restoration with antisense oligonucleotide PRO051. N Engl J Med. 357, 2677-2686.
26. White, S., Kalf, M., Liu, Q., Villerius, M., Engelsma, D., Kriek, M., Vollebregt, E., Bakker, B., van Ommen, G. J., Breuning, M. H., & den Dunnen, J. T. (2002). Comprehensive detection of genomic duplications and deletions in the DMD gene, by use of multiplex amplifi able probe hybridization. Am J Hum Genet, 71, 365-374.